期刊文献+

基质金属蛋白酶-2在盐型高血压大鼠心脏中的表达及不同种类降压药物的影响

The Signifance of Expression of MMP-2 and the Effect of the Intervention of Different Antihypertensive Drugs in DHR Heart
下载PDF
导出
摘要 目的探讨基质金属蛋白酶-2/基质金属蛋白酶-2特异性组织抑制因子(MMP-2/TI MP-2)在脱氧皮质酮(DOCA)-盐型高血压大鼠(DHR)心脏微小血管重塑中的作用及其可能的调节机制。方法30只雄性SD大鼠,等分和制作为对照组、模型组、波生坦组、氨氯地平组和雷米普利组。5周末处死动物,检测心脏微小血管密度和MMP-2/TI MP-2蛋白与基因的表达。结果在DHR左心室心内膜下心肌中存在微小动脉密度增加和毛细血管密度减少,MMP-2的mRNA和MMP-2/TI MP-2的蛋白表达上调;波生坦和氨氯地平能明显减轻微小血管损害,下调MMP-2/TI MP-2的mRNA和蛋白表达;雷米普利不能减轻微小血管损害,也不影响MMP-2/TI MP-2的mRNA和蛋白表达;MMP-2的表达同微小血管密度间具有良好的相关性。结论在DHR心脏中存在微小血管病变,MMP-2/TI MP-2表达可能参与微小血管病变的病理机制,内皮素-1和血压可能是通过调节MMP-2/TI MP-2表达参与微小血管病变。 Objective: To explore the role of MMP-2/TIMP-2 in the remodeling of cardiac microvasular of DOCA-salt hypertensive rats(DHR), and investigate the mechanism of it.Method: Thirty male Sprague-Dawley rats were unilaterally neprectomiled, and were divided into 5 groups including control, placebo, bosentan, amlodipine and ramipril group. They were plot to death after 5 weeks treatment. The arteriolar and capillary density, and the expression of MMP-2/TIMP-2 protein were employed to evaluate in the subendocardial myocardium of the left ventricular tissue. RT-PCR was used to measure the expression of mRNA of MMP-2/TIMP-2. Results: DOCA-salt hypertensive rats exhibited a marked decrease of microvascular density,and an increase of expression of MMP-2/TIMP-2. Amlodipine nearly normalized arterial pressure and suppressed all these changes. Bosentan had a very small effect on arterial pressure but decreased microvasular density and downregulated the expression of MMP-2/TIMP-2. Ramipril had no effect on arterial pressure,microvascular density and the expression of MMP-2/TIMP-2.Conclusion: Humoral factors such as endothelin may play a role besides high blood pressure in microvascular density in DOCA salt hypertension.MMP-2/TIMP-2 may play an important role in microvascular change.
出处 《微循环学杂志》 2005年第4期17-21,F0002,共6页 Chinese Journal of Microcirculation
  • 相关文献

参考文献13

  • 1Levy BI, Ambrosio G, Pries AR, et al. Microcirculation in hypertension: A New Target for Treatment? Circulation,2001, 104(6): 735~741.
  • 2Ergul Α, Portik-Dobos V, Giulumian AD, et al. Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation. American Journal of Physiology: Heart & Circulatory Physiology,2003, 54 (5):2 225~2 232.
  • 3Francis G, Mytis LS, Brain RC, et al. Myocardial matrix degradation and metalloproteinase activation in the failing heart:a potential therapeutic target.Cardiovascular Research,2000,46(2):225~238.
  • 4Kubo T. Animal models DOCA-slat hypertension. Jpn Hypertens, 2001, 58 (suppl): 708~711.
  • 5Ammarguellat FZ, Gannon PO, Amiri F, et al.Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors. Hypertension,2002,39 (2 Pt 2): 679~684.
  • 6Robert V, Besse S, Sabri A, et al. Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. Laboratory Investigation,1997, 76(5): 729~738.
  • 7Coker ML, Jolly JR, Joffs C, et al. Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation. American Journal of Physiology-Heart & Circulatory Physiology,2001, 281(2): H543~551.
  • 8Fernandez-Patron C, Zouki C, Whittal R, et al. Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1. FASEB,2001, 15(12): 2 230~2 240.
  • 9Johnson JL, Jackson CL, Angelini GD, et al. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques.Arterioscler Thromb Vasc Biol,1998,18(11):1 707~1 715.
  • 10Fernandez-Patron C, Stewart KG, Zhang Y, et al. Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circulation Research,2000, 87 (8): 670~676.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部